Search Result "Nivolumab"
A Case of Cancer-Associated Hyponatraemia: Primary Adrenal InsufficiencySecondary to Nivolumab
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 22 Issue: 3 Year: 2022 Page: 363-366
Author(s): Ernesto De Menis,Michela Bortolin,Paola Sartorato,Filippo Morando,Silvia Galliazzo
Immunotherapy of Human Melanoma: Past, Present, Future
Journal: Current Medicinal Chemistry
Volume: 32 Issue: 18 Year: 2025 Page: 3548-3570
Author(s):
Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?
Journal: Reviews on Recent Clinical Trials
Volume: 11 Issue: 2 Year: 2016 Page: 81-86
Author(s): Marlana Orloff, Ryan Weight, Matias E. Valsecchi, Takami Sato
Treatment of Metastatic Renal Cell Carcinoma with Checkpoint Inhibitors inClinical Practice in the Volga-Ural Region of the Eurasian Continent
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 41 Year: 2023 Page: 3312-3323
Author(s): Radmir R. Rakhimov,Aleksandr V. Sultanbaev,Adel A. Izmailov,Konstantin V. Menshikov,Vadim M. Zabelin,Albert A. Izmailov,Gulshat R. Gilyazova,Svetlana M. Izmailova,Ksenia S. Bakhtiyarova,Irina R. Gilyazova,Angelina A. Izmailova
Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
Journal: Current Drug Safety
Volume: 11 Issue: 1 Year: 2016 Page: 62-68
Author(s): Assunta Sgambato, Francesca Casaluce, Paola C. Sacco, Giovanni Palazzolo, Paolo Maione, Antonio Rossi, Fortunato Ciardiello, Cesare Gridelli
Occurrence and Severity of Adverse Reactions of Immune CheckpointInhibitors (PD-1 and PD L1) Based on Mordovian Dispensary DataAnalysis
Journal: Current Cancer Therapy Reviews
Volume: 18 Issue: 1 Year: 2022 Page: 51-56
Author(s): Basheer Marzoog
The New Immunotherapy Combinations in the Treatment of Advanced Non-Small Cell Lung Cancer: Reality and Perspectives
Journal: Current Clinical Pharmacology
Volume: 15 Issue: 1 Year: 2020 Page: 11-19
Author(s): Danilo Rocco,Luigi D. Gravara,Cesare Gridelli
Assessment of Neurologic Safety Profile of Immune Checkpoint Inhibitors:Evaluation of Adverse Drug Reaction Reports
Journal: Current Drug Safety
Volume: 19 Issue: 3 Year: 2024 Page: 382-394
Author(s): Mandeep Kumar Arora
Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 3 Year: 2015 Page: 307-313
Author(s): Sara Pilotto,Stefania Kinspergher,Umberto Peretti,Anna Calio,Luisa Carbognin,Roberto Ferrara,Matteo Brunelli,Marco Chilosi,Giampaolo Tortora,Emilio Bria
Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer
Journal: Reviews on Recent Clinical Trials
Volume: 11 Issue: 4 Year: 2016 Page: 297-305
Author(s): Anshu Giri,Simrit S. Walia,Ajeet Gajra